Research on the cell biology of tumors. Covers cancer-cell vulnerabilities, tumor spread, nanoreactor therapies, and AI-guided cancer research.
Researchers at Binghamton University will study biofilms implicated in 80% of infectious diseases using a new fluorescence-activated cell sorter. The machine allows for separation and analysis of subpopulations of cells without killing them.
Researchers discovered a new water-soluble fluorescent detection system that is extremely sensitive to pyrophosphate, which plays a key role in energy transduction and DNA replication in cancer cells. The discovery may lead to improved cancer diagnostics.
Researchers at Virginia Tech developed a novel method to detect the subcellular location of proteins, which will enable improved patient monitoring and drug development. The technique allows for rapid screening of large cell populations with high resolution, revealing heterogeneity among cells.
Researchers at VCU Massey Cancer Center have identified a critical protein called Noxa, which helps regulate the function of MCL-1 and makes cancer cells more sensitive to ABT-737. This breakthrough may lead to improved therapies for small cell lung cancer, overcoming resistance to conventional chemotherapies.
Scientists at the University of Texas at Dallas are investigating the potential human health effects of multi-walled carbon nanotubes, tiny structures used in various products. The researchers will use advanced microscopy techniques to track how these nanotubes interact with human cells and determine their impact on health.
Using the subway analogy, a physicist is applying queuing theory to study protein traffic jams in cells. By understanding these bottlenecks, he aims to discover mechanisms for alleviating them and develop new tools for synthetic biology. This research has the potential to impact areas such as development, inflammation and cancer.
Researchers at Beth Israel Deaconess Medical Center have identified a key enzyme responsible for lactate production in cancer cells, which they inhibit to halt tumor growth and even cause regression. The study's findings offer promising results for new treatments targeting cancer metabolism.
Researchers at UC Davis have identified the atomic structure of kinesin-5, a protein essential for mitosis in virtually all eukaryotic cells. The newly discovered structure reveals unique pockets that could be exploited as targets for new anti-cancer drugs.
Researchers develop a new strategy to kill bladder cancer cells by attaching gold nanorods to EGFR proteins, which are overexpressed on these cells. The application of low-intensity laser heat the nanorods, killing the cancer cells without harming healthy tissue.
A University of Colorado study shows that cancer cells can outlive chemotherapies by using autophagy, a process where cells recycle damaged parts. This finding has implications for developing drugs that inhibit autophagy to sensitize cancer cells to chemotherapy.
Researchers at Lund University have developed a technique using magnetically controlled nanoparticles to selectively kill cancer cells while sparing healthy tissue. This method has the potential to revolutionize cancer treatment by reducing side effects associated with traditional therapies.
A new study published in the journal Cancer has identified a novel biomarker, CCTα, associated with improved survival rates in patients with head and neck cancers and non-small cell lung cancer. The findings suggest that CCTα may be a more important predictor of patient outcomes than previously established ERCC1.
A comprehensive 'roadmap' of blood cells has been presented by researchers, pinpointing the location of key genetic regulators that determine cell development and function. This robust genetic catalog will enable hematologists to trace the development of blood cells and identify potential triggers for malignancies.
Researchers discovered that p53 acts to prevent cancer cell invasion by initiating a chain of events that ultimately prevents the formation of lamellipodia. This process involves the activation of a mitochondrial protease called Omi, which cleaves actin filaments and suppresses the activity of focal adhesion signaling protein p130Cas.
Researchers at Massachusetts General Hospital have identified a path to safer drugs for heart disease and cancer. By analyzing the structure of an extracellular matrix protein and its interaction with an integrin, they have discovered a high-affinity version that can bind strongly without inducing unintended receptor activation.
Scientists at Northwestern University have discovered that cancer cells rely on the FAS receptor and its binding component for survival, making them vulnerable to elimination. The team created a cancer cell completely devoid of CD95, which resulted in DNA damage and cell death, offering a promising new approach to kill cancer cells.
A team of biologists and engineers at the University of California, San Diego has discovered how white blood cells generate traction forces to propel themselves forward by coordinated action of contractile proteins. This finding is crucial for developing new pharmacological strategies to treat chronic inflammatory diseases.
Researchers have identified a key pathway that helps cancer cells survive in low-glucose environments, and found that certain diabetes drugs can inhibit this pathway to kill cancer cells. The study provides new insights into how anti-cancer properties of diabetes drugs like metformin may work.
Researchers found that just a handful of genetic mutations give E. coli the capacity to withstand ionizing radiation, making them similar to Deinococcus radiodurans. The study demonstrates active DNA repair mechanisms that allow organisms to resist radiation damage.
Researchers have developed a versatile mouse that expresses a fluorescent biosensor, enabling the tracking of diseased cells and drugs in real-time. This technology has been used to monitor Rac activation in various organs in response to drug treatment, providing valuable information on cancer progression.
A recent study reveals that a key protein called IRSp53 plays a crucial role in regulating cell movement, which is necessary for wound healing and immune response. However, when cancer cells break away from tumors and migrate to other tissues, this regulation can be disrupted, leading to metastasis.
Researchers at Johns Hopkins University have discovered that cancer cells do not follow a 'drunken' walk through the body, but rather move in more direct lines. This new understanding could lead to more accurate results for scientists studying how cancer spreads and may lead to more effective treatments.
Researchers from Imperial College London have discovered that blocking Hhat slows pancreatic cancer growth by preventing Hedgehog from stimulating nearby cells. The study found that genetic techniques could prevent the process from starting in the first place, leading to reduced cancer cell growth and ability to spread.
Researchers found that a common mutation activates the Akt pathway, rendering cells resistant to chemotherapy and increasing growth. Inhibition of this pathway restored leukemic cell responses to front-line therapy.
A team of researchers has created a detailed analysis of protein activity in human cancer cells, revealing the dynamic patterns of gene expression during the cell cycle. The study provides new insights into how genes work over time in cancer cells and could lead to the development of safer new drugs.
A team of researchers at New York University and the University of Texas at Austin has discovered that carbohydrates serve as unique identifiers for cancer cells. By analyzing the role of microRNA in regulating carbohydrate structures, the study reveals a new way to detect cancer using sugar-based biomarkers.
Researchers have discovered that some tumors behave less aggressively in microgravity compared to on Earth, sparking hope for new cancer treatments. The unique conditions of space exploration offer insights into genetic and cellular processes that cannot be replicated on land.
A new study by Rutgers researchers reveals that eliminating the eEF2K enzyme could strengthen healthy cells, making them resilient to cancer treatment. This breakthrough may lead to more powerful treatments with fewer debilitating side effects, paving the way for improved cancer therapies.
Scientists at DESY's PETRA III research light source used nanodiffraction to study living cancer cells, showing clear differences in their internal structures compared to chemically fixed cells. The technique enabled the investigation of living cells in their natural environment using hard X-rays.
Researchers at Fox Chase Cancer Center have discovered a new mechanism of gene regulation that involves the modification of histones, leading to the activation of PARP1 and exposure of specific genes. This finding has significant implications for cancer treatment and may lead to the development of more effective therapies.
Researchers have discovered caffeine-based gold compounds that selectively kill human ovarian cancer cells without harming healthy cells. The new compounds target a specific DNA architecture associated with cancer, offering a potential tool in the fight against cancer.
Researchers at Argonne National Laboratory developed a hard X-ray fluorescence nanoprobe that preserves the natural state of cells and trace elements by rapidly cooling them to -260°F. This enables the creation of high-resolution images with unprecedented detail, solving long-standing issues in biological imaging.
Research reveals that Mdm2 suppresses tumor growth by inhibiting glycolysis through the degradation of PGAM. This process prevents cells from entering senescence and allows them to continue proliferating. The study provides new insights into how damaged cells respond to stress and offers potential avenues for cancer treatment.
Tc toxin complexes, used by bacteria like Yersinia pestis and Photorhabdus luminescens, have been imaged with atomic detail. The complexes use an elastic band-like protein chain to penetrate cell membranes, depositing toxic enzymes. This mechanism has potential applications in medicine, including selectively targeting cancer cells.
A new study at the University of Liverpool explains how cells adapt to low oxygen environments, potentially controlling cell survival signals. By monitoring protein levels and gene expression, researchers discovered optimal conditions for keeping cells alive, which could lead to cancer treatment advancements.
Researchers at Karolinska Institutet have identified a new drug candidate, VLX600, that selectively kills dormant cancer cells in solid tumors by starving them. The drug works by inhibiting mitochondrial respiration, causing the cells to die from starvation. A clinical study is planned to take place this year.
Kidney cancer cells exhibit distinct metabolic differences compared to other cancers, providing a potential weak link for diagnosis and treatment. This discovery opens the door to new biomarkers and therapeutic approaches for detecting kidney cancer at an early stage.
Researchers have developed 'smart' gold nanoshells that target cancer cells specifically, delivering anticancer drugs and converting near-infrared light into heat. This breakthrough could lead to more effective cancer treatments by overcoming the limitation of traditional chemotherapy techniques.
Researchers have discovered how the protein Bcl-2 signals cancer cells to live longer by altering calcium ion levels. This breakthrough could lead to new drugs targeting Bcl-2 and improve cancer treatment outcomes.
Researchers at the University of Adelaide found that grape seed extract improves chemotherapy's potency and reduces intestinal damage in laboratory studies. Grape seed extracts showed no side effects on healthy intestine, decreased inflammation by up to 55%, and increased growth-inhibitory effects on colon cancer cells.
Researchers at NIST developed a new method to accurately measure changes in living cell redox potential, which can serve as an indicator of cellular health and function. The technique uses nuclear magnetic resonance spectroscopy to detect glutathione levels and monitor intracellular redox reactions.
Innate lymphoid cells play key roles in protecting against infection or parasites, but their origin and function were unknown until now. Researchers identify ILCPs in fetal liver and adult bone marrow, paving the way for a better understanding of the immune system's first line of defense.
Researchers have developed a new live-cell printing technology called BloC-Printing that can print living cells onto any surface in a grid-like formation. The technology, which manipulates microfluidic physics to guide cells into hook-like traps, produces high survival rates of over 100% compared to traditional inkjet printing.
Researchers successfully controlled nanomotors inside live human cells, powered by ultrasonic waves and steered magnetically. The ability to manipulate cells from the inside holds promise for treating diseases such as cancer.
Researchers aim to make blood cancers more vulnerable to treatment by targeting the hiding spots where leukemia cells reside. Initial focus is on blood vessels, which provide a safe haven for these cells.
Researchers studied how a protein complex called Mre11-Rad50 reshapes itself to take on different DNA-repair tasks, revealing insights into its dynamic structure and biological outcomes. The findings could guide the development of better cancer-fighting therapies and more effective gene therapies.
Researchers found that aggressive thyroid cancer cells in microgravity exhibit a redifferentiation to a less aggressive state, offering hope for new treatments. The study's findings suggest potential therapeutic targets for cancer drugs that may be effective on Earth.
Researchers discovered that DNA damage triggers dramatic reorganization of the Golgi, leading to its dispersal throughout the cell. This dispersal involves a novel signaling pathway directly linking DNA damage response to the Golgi, affecting cell survival and chemotherapy efficacy.
A study by Virginia Tech researchers reveals that brain tumor cells with diverse physical traits are safer due to chromosomal abnormalities. These abnormalities lead to cell diversity and survival of brain tumors.
Researchers discovered a targeted treatment's mechanism of action, which involves the PML/p53 pathway and senescence. The treatment's effectiveness relies on reorganizing nuclear bodies and triggering p53 activation, leading to the elimination of cancer cells and patient recovery.
Researchers from University of Copenhagen develop method for slow release drugs by attaching liquid crystalline particles to cancer cells. The particles can carry large quantities of drugs and interact with cellular membranes, providing a potential solution to frequent injections and side effects.
Researchers at the University of Edinburgh have discovered a set of proteins that stabilise cell division, which could lead to new avenues in drug discovery for fighting cancer. The findings shed light on how cells duplicate their DNA and separate into two new cells, each identical to the original.
A new study suggests that autophagy plays a key role in determining the fate of cancer cells when treated with anti-cancer drugs. Cells with high levels of autophagy were more susceptible to death from certain drugs, while those with low levels of autophagy were more resistant.
The study reveals that E6AP is composed of three distinct protein molecules, controlling nerve cell function and viral replication. This breakthrough provides potential drug targets for autism and cervical cancer treatment.
Researchers found that activating p53 in normal cells induces Par-4 secretion, killing cancer cells. The paracrine effect targets tumor cells at distant sites, offering a new approach to treating tumors resistant to other treatments.
Researchers have discovered that a cancer drug can protect the insulin-producing cells in the pancreas and prevent the development of type 1 diabetes in mice. The medication works by reducing sterile inflammation and delaying cell destruction. This finding is a step towards developing a preventive treatment for type 1 diabetes.
Walter and Eliza Hall Institute researchers discovered that lymphoma cells with high levels of MYC are sensitive to disabling protein MCL-1, making it a potential target for treating cancers driven by this common cancer-causing change in cells.
Researchers at Cornell University have discovered a new way to destroy metastasizing cancer cells by hitching killer proteins to white blood cells. The treatment, which uses E-selectin and TRAIL proteins, was found to be nearly 100% effective in killing cancer cells in laboratory tests.
Researchers at the University of California, San Diego School of Medicine found that combining ROR1 and TCL1 oncogenes in mice accelerates and worsens blood cancer. The study suggests ROR1 could be an important therapeutic target for patients with CLL, a common form of blood cancer affecting over 15,000 new cases annually.
Scientists at the University of Exeter have identified four distinct routes for cell division, which could lead to errors in cell division and increase cancer risk. The study also found a central molecular complex, Augmin, essential for all these pathways.